FLAXSEED IS: SOURCE OF ESSENTIAL FATTY ACIDS FOR THE MAINTENANCE OF GOOD HEALTH. SOURCE OF OMEGA-3 FATTY ACIDS FOR THE MAINTENANCE OF GOOD HEALTH. SOURCE OF ALPHA-LINOLENIC ACID (ALA) FOR THE MAINTENANCE OF GOOD HEALTH. SOURCE OF OMEGA-6 FATTY ACIDS FOR THE MAINTENANCE OF GOOD HEALTH. SOURCE OF LINOLEIC ACID (LA) FOR THE MAINTENANCE OF GOOD HEALTH. (USED IN HERBAL MEDICINE AS A) BULK-FORMING LAXATIVE. (USED IN HERBAL MEDICINE TO) PROMOTE(S) BOWEL MOVEMENT BY INCREASING BULK VOLUME AND WATER CONTENT. (USED IN HERBAL MEDICINE TO) PROVIDE(S) GENTLE RELIEF OF CONSTIPATION AND/OR IRREGULARITY. (USED IN HERBAL MEDICINE TO) HELP(S) REDUCE BLOOD LIPID LEVELS IN ADULTS. PROVIDES ANTIOXIDANTS FOR THE MAINTENANCE OF GOOD HEALTH. CAUTIONS AND WARNINGS CONSULT A HEALTH CARE PRACTITIONER IF SYMPTOMS WORSEN OR IF LAXATIVE EFFECT DOES NOT OCCUR WITHIN SEVEN DAYS. CONSULT A HEALTH CARE PRACTITIONER IMMEDIATELY IF YOU EXPERIENCE CHEST PAIN, VOMITING, OR DIFFICULTY IN SWALLOWING OR BREATHING AFTER TAKING THIS PRODUCT. CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE IF YOU ARE EXPERIENCING A SUDDEN CHANGE IN BOWEL HABITS THAT HAS PERSISTED FOR MORE THAN 2 WEEKS, UNDIAGNOSED RECTAL BLEEDING, OR HAVE FAILED TO DEFAECATE FOLLOWING THE USE OF A LAXATIVE PRODUCT. CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE IF YOU ARE TAKING MEDICATIONS WHICH INHIBIT PERISTALTIC MOVEMENT (E.G. OPIOIDS, LOPERAMIDE). CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE IF YOU HAVE DIABETES. CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE IF YOU HAVE DIFFICULTY SWALLOWING. CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE IF YOU HAVE SYMPTOMS SUCH AS ABDOMINAL PAIN, NAUSEA, VOMITING OR FEVER (AS THESE COULD BE SIGNS OF ABNORMAL CONSTRICTIONS OF THE GASTROINTESTINAL TRACT, DISEASES OF THE OESOPHAGUS AND/OR THE SUPERIOR OPENING OF THE STOMACH (CARDIA), POTENTIAL OR EXISTING INTESTINAL BLOCKAGE, PARALYSIS OF THE INTESTINE, MEGACOLON, FAECAL IMPACTION, INFLAMED BOWEL OR APPENDICITIS). KNOWN ADVERSE REACTIONS HYPERSENSITIVITY, SUCH AS AN ALLERGY, HAS BEEN KNOWN TO OCCUR IN RARE CASES; IN WHICH CASE, DISCONTINUE USE. MAY CAUSE TEMPORARY GAS AND BLOATING. NAKAJIMA Y, SATO Y, KONISHI T. ANTIOXIDANT SMALL PHENOLIC INGREDIENTS IN INONOTUS OBLIQUUS (PERSOON) PILAT (CHAGA). CHEMICAL PHARMACEUTICAL BULLETIN 2007; 55(8):1222-1226. WON DP, LEE JS, KWON DS, LEE KE, SHIN WC, HONG EK. IMMUNOSTIMULATING ACTIVITY BY POLYSACCHARIDES ISOLATED FROM FRUITING BODY OF INONOTUS OBLIQUUS. MOLECULES AND CELLS 2011; 31(2):165-173. YOUN MJ, KIM JK, PARK SY, KIM Y, PARK C, KIM ES, PARK KI, SO HS, PARK R. POTENTIAL ANTICANCER PROPERTIES OF THE WATER EXTRACT OF INONOTUS OBLIQUUS BY INDUCTION OF APOPTOSIS IN MELANOMA B16-10 CELLS. JOURNAL OF ETHNOPHARMACOLOGY 2009; 121(2):221-228. DU XJ, MU H, ZHOU S, ZHANG Y, ZHU XL. CHEMICAL ANALYSIS AND ANTIOXIDANT ACTIVITY OF POLYSACCHARIDES EXTRACTED FROM INONOTUS OBLIQUUS SCLEROTIA. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 2013; 62:691-696. JU HK, CHUNG HW, HONG SS, PARK JH, LEE J, KWON SW. EFFECT OF STEAM TREATMENT ON SOLUBLE PHENOLIC CONTENT AND ANTIOXIDANT ACTIVITY OF THE CHAGA MUSHROOM (INONOTUS OBLIQUUS). FOOD CHEMISTRY 2008; 119(2):619-625. NING X, LUO Q, LI C, DING Z, PANG J, ZHAO C. INHIBITORY EFFECTS OF A POLYSACCHARIDE EXTRACT FROM THE CHAGA MEDICINAL MUSHROOM, INONOTUS OBLIQUUS (HIGHER BASIDIOMYCETES), ON THE PROLIFERATION OF HUMAN NEUROGLIOCYTOMA CELLS. INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS 2014; 16(1):29-36. This page is not intended to be a comprehensive review of the medicinal ingredient.